408.30
-11.95(-2.84%)
Currency In INR
Address
B-1 Extension/G-3
New Delhi, 110044
India
Phone
91 11 4167 9000
Sector
Healthcare
Industry
Biotechnology
Employees
1936
First IPO Date
July 01, 2002
Name | Title | Pay | Year Born |
Mr. Ankesh Jain | Whole-Time Director | 3.03M | 1989 |
Mr. Sandeep Jain | Joint MD & Executive Director | 8.37M | 1966 |
Dr. Rajesh Jain Ph.D. | Chairman of the Board & MD | 9.01M | 1964 |
Dr. Khalid Al Syed | Chief Scientific Officer | 0 | 1975 |
Mr. Vinod Goel | Group Chief Financial Officer, Head of Legal, Company Secretary & Compliance Officer | 0 | 1965 |
Dr. Rajeeva Kumar Mangalum | Chief Operating Officer | 0 | 1961 |
Naresh Chand Gupta | General Manager of Accounts & Taxation | 0 | N/A |
Mr. Devender Gupta | Chief Financial Officer & Head of Information Technology | 0 | 1973 |
Mr. Ashish Jain | Chief Information Officer | 0 | N/A |
Mr. Gurinder Pal Singh | Senior Vice President of Sales | 0 | 1967 |
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.